Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Matteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 275-286
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Carlo Cervia, Sarah C. Brüningk, Tobias Hoch, et al.
Science (2024) Vol. 383, Iss. 6680
Open Access | Times Cited: 182
Humoral Innate Immunity and Acute-Phase Proteins
Alberto Mantovani, Cecília Garlanda
New England Journal of Medicine (2023) Vol. 388, Iss. 5, pp. 439-452
Open Access | Times Cited: 134
COVID-19 2022 update: transition of the pandemic to the endemic phase
Michela Biancolella, Vito Luigi Colona, Ruty Mehrian‐Shai, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 118
Immune response in COVID-19: what is next?
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 639
Open Access | Times Cited: 99
Long Covid: where we stand and challenges ahead
Alberto Mantovani, Maria Concetta Morrone, Carlo Patrono, et al.
Cell Death and Differentiation (2022)
Open Access | Times Cited: 98
A guide to complement biology, pathology and therapeutic opportunity
Dimitrios C. Mastellos, George Hajishengallis, John D. Lambris
Nature reviews. Immunology (2023) Vol. 24, Iss. 2, pp. 118-141
Closed Access | Times Cited: 95
Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation
Ting Gao, Lin Zhu, Hainan Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 86
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 604-611
Open Access | Times Cited: 64
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Kirsten Baillie, Helen Davies, Samuel Keat, et al.
Med (2024) Vol. 5, Iss. 3, pp. 239-253.e5
Open Access | Times Cited: 22
The Lectin Pathway of the Complement System—Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems
József Dobó, Andrea Kocsis, Bence Farkas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1566-1566
Open Access | Times Cited: 16
Complement activation in COVID-19 and targeted therapeutic options: A scoping review
Endry H. T. Lim, Rombout B. E. van Amstel, Vieve Victoria de Boer, et al.
Blood Reviews (2022) Vol. 57, pp. 100995-100995
Open Access | Times Cited: 46
Principles of SARS-CoV-2 glycosylation
Himanshi Chawla, Elisa Fadda, Max Crispin
Current Opinion in Structural Biology (2022) Vol. 75, pp. 102402-102402
Open Access | Times Cited: 39
Tissue factor in COVID-19-associated coagulopathy
Saravanan Subramaniam, Hema Kothari, Markus Bosmann
Thrombosis Research (2022) Vol. 220, pp. 35-47
Open Access | Times Cited: 37
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27
Genetic susceptibility to severe COVID-19
Claudio Cappadona, Valeria Rimoldi, Elvezia Maria Paraboschi, et al.
Infection Genetics and Evolution (2023) Vol. 110, pp. 105426-105426
Open Access | Times Cited: 26
DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins
Yanchao Liu, Youzhuo Zhu, Xin Sun, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 820-820
Open Access | Times Cited: 22
PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation
Dylan P. Noone, Douwe J. Dijkstra, Teun T. van der Klugt, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 33
Open Access | Times Cited: 29
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Haiyun Yu, Fei Guan, Heather Miller, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
Hao Zhang, Ruixuan Wang, Zeyu Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113783-113783
Open Access | Times Cited: 28
Pattern-recognition receptors (PRRs) in SARS-CoV-2
Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, et al.
Life Sciences (2023) Vol. 329, pp. 121940-121940
Closed Access | Times Cited: 17
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
Lisa Hurler, Ágnes Szilágyi, Federica Mescia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Organokines in COVID-19: A Systematic Review
Sandra Maria Barbalho, Giulia Minniti, Vitor Fernando Bordin Miola, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1349-1349
Open Access | Times Cited: 15
Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model
Ikechukwu B. Jacob, Amanda Gemmiti, Weichuan Xiong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top